Has Nalini Mehtani received payments from drug or device companies?

Yes. Drug and device makers reported $9,452 in general payments to Nalini Mehtani across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nalini Mehtani did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nalini Mehtani come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nalini Mehtani

Family Medicine · Sacramento, CANPI 1043364995

Payments from drug & device makers

$9,452in general payments, 2019–2025

Across 97 payments — averaging $97.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$2K
Otsuka America Pharmaceutical, Inc.$1K
Johnson & Johnson$1K
Teva Pharmaceuticals USA, Inc.$1K
Alkermes, Inc.$660
E.r. Squibb & Sons, L.L.C.$473
plus $3K from 20 others

What the payments were for

Food & beverage$9,452100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	16	$1,746
Otsuka America Pharmaceutical, Inc.	15	$1,371
Johnson & Johnson	10	$1,107
Teva Pharmaceuticals USA, Inc.	10	$1,107
Alkermes, Inc.	8	$660
E.r. Squibb & Sons, L.L.C.	4	$473
Sunovion Pharmaceuticals Inc.	6	$383
AstraZeneca(2 entities)	2	$242
Clovis Oncology, Inc.	2	$224
Biogen	2	$223
Vanda Pharmaceuticals Inc.	2	$218
Incyte Corporation	2	$213
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$188
Neuronetics, Inc.	2	$184
AbbVie	2	$153
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$125
Gilead	1	$122
GSK	1	$120
Boehringer Ingelheim	1	$113
Amgen	1	$101
Jazz Pharmaceuticals Inc.	1	$101
Luye Pharma (USA) Ltd.	1	$97
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$73
Lilly USA, LLC	1	$67
Merck	2	$28
Lundbeck LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,452 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Sacramento

Amina HaggagNorthridge$112.8M
Steven ReynoldsLong Beach$53M
Rizwana MohseniLake Forest$26.7M
Daniel JohnsonSan Diego$15.7M
Stacey LayleSan Diego$14.8M
Apinya VutikullirdCypress$14.3M
Hanid AudishSpring Valley$13.6M
Augusto FocilOxnard$12.6M
Jack VuLong Beach$10.1M
Suzanne FussellOxnard$8.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →